Skip to main content
GENESIS IBRC INDIA LIMITED logo

GENESIS IBRC INDIA LIMITED — Investor Relations & Filings

Ticker · 514336 ISIN · INE194N01016 BSE.NS Manufacturing
Open in API
Filings indexed 311 across all filing types
Latest filing 2025-02-07 Regulatory Filings
Country IN India
Listing BSE.NS 514336

About GENESIS IBRC INDIA LIMITED

https://genesisiil.com/

Genesis IBRC India Limited is a biotechnology-driven enterprise focused on the research, development, and commercialization of advanced biological solutions. The company specializes in the production of high-quality probiotics and industrial enzymes tailored for diverse applications. Its product portfolio serves critical sectors including aquaculture, poultry, animal husbandry, and human nutrition, providing microbial formulations designed to enhance growth, immunity, and overall health. In the industrial segment, the company develops enzymatic solutions for the textile, leather, and paper processing sectors to improve efficiency and environmental sustainability. Genesis IBRC emphasizes innovation through its dedicated research facilities, focusing on strain selection and fermentation technology to deliver standardized and effective biochemical products. The company aims to provide science-based alternatives to traditional chemical processes across global markets.

Recent filings

Filing Released Lang Actions
Genesis Ibrc India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve With reference to the subject ....
Regulatory Filings Classification · 95% confidence The document is a notice from Genesis IBRC India Limited informing the Bombay Stock Exchange about an upcoming Board Meeting scheduled for February 14, 2025. The purpose of the meeting includes considering and approving the unaudited financial results for the third quarter ended December 31, 2024. The document references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures related to board meetings and financial results. The document is short (1304 characters) and serves as an announcement of a meeting rather than containing any financial data or results itself. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as it is a general regulatory announcement about the board meeting and upcoming financial results approval.
2025-02-07 English
Certificate under reg 74 (5) of SEBI (DP) Regulations
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st December 2024. It is a compliance certificate from the Registrar and Transfer Agent confirming dematerialisation and updating of securities records. The document is short (2804 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and regulatory announcements that do not fit other specific categories.
2025-01-20 English
Closure of Trading window
Regulatory Filings Classification · 95% confidence The document is a letter from Genesis IBRC India Limited addressed to the BSE Limited Corporate Relations Department. It announces the closure of the trading window for insiders from January 1, 2025, until 48 hours after the declaration of the company's unaudited financial results for the third quarter ended December 31, 2024. The letter references compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and mentions that the date of the Board Meeting for the financial results will be intimated later. The document does not contain any financial data or results itself, nor does it present a report or detailed financial information. Instead, it is an announcement related to insider trading restrictions ahead of a financial results announcement. This type of document is best classified as a Regulatory Filing (RNS), as it is a regulatory announcement that does not fit into other specific categories and is not a report or financial statement.
2024-12-26 English
Statement of deviation
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Corporate Relations Department of BSE Limited, dated 14.11.2024, disclosing information under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It states that the regulation is not applicable as the company has not raised any funds and hence no annexure is submitted. The document is a regulatory disclosure related to compliance with SEBI regulations, specifically about deviation or variation in proceeds of public issues or similar fundraising activities, but it explicitly states no funds were raised. The document is short (1339 characters) and serves as a regulatory compliance disclosure rather than a financial report or detailed update. It does not contain financial data, management discussion, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2024-11-14 English
Submissions of unaudited results
Regulatory Filings
2024-11-14 English
This is to inform that, the Board of Directors of the Company in their just concluded meeting had, inter-alia, transacted the following items of business: 1. Approved the Un-audited ....
Regulatory Filings Classification · 95% confidence The document is a short announcement from Genesis IBRC India Limited addressed to the BSE Limited, reporting the outcome of a Board Meeting held on 14.11.2024. It specifically mentions the approval of Un-audited Financial Results along with a Limited Review Report for the second quarter and half year ended September 30, 2024. The document references SEBI Listing Obligations and Disclosure Requirements Regulations, indicating a regulatory compliance announcement. The length is only 1340 characters, which is quite short and does not contain the actual financial statements or detailed analysis, but rather informs about the approval and review of such results. According to the MENU VS MEAL RULE, this is an announcement of the financial results and limited review report, not the full interim/quarterly report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement about the board meeting outcome and financial results approval, not the full report or detailed financial data.
2024-11-14 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.